Device Trial Radar · NCT02528552
Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
Last checked: Nov 20, 2026Latest source record: Dec 2, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
80
Planned (sponsor's estimate)
Start
Aug 2015
Primary completion
Oct 2016
Study completion Dec 2016
Sponsor
- Lead sponsor
- Theradome, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 19, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a prospective, randomized double-blind, multi-center study to evaluate the efficacy of low level laser therapy over-the-counter at home device Theradome LH80 PRO, compared to SHAM for promoting hair growth in males diagnosed with androgenetic alopecia, and a usability study to assess subject ability to self-assess hair loss and understanding use of the device.
Conditions
- Androgenetic Alopecia
Interventions
LH80 PRODevice
Sham DeviceDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hair growthTime frame: 26 weeks
1 more outcomes with a free account
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Axis Clinical Tirals
Los Angeles, California
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.